| Cancer-associated fibroblasts in the single-cell era D Lavie, A Ben-Shmuel, N Erez, R Scherz-Shouval Nature cancer 3 (7), 793-807, 2022 | 257 | 2022 |
| Unleashing natural killer cells in the tumor microenvironment–the next generation of immunotherapy? A Ben-Shmuel, G Biber, M Barda-Saad Frontiers in immunology 11, 275, 2020 | 133 | 2020 |
| Dephosphorylation of the adaptor LAT and phospholipase C–γ by SHP-1 inhibits natural killer cell cytotoxicity O Matalon, S Fried, A Ben-Shmuel, MH Pauker, N Joseph, D Keizer, ... Science signaling 9 (429), ra54-ra54, 2016 | 74 | 2016 |
| Actin retrograde flow controls natural killer cell response by regulating the conformation state of SHP‐1 O Matalon, A Ben‐Shmuel, J Kivelevitz, B Sabag, S Fried, N Joseph, ... The EMBO journal 37 (5), e96264, 2018 | 56 | 2018 |
| The role of the cytoskeleton in regulating the natural killer cell immune response in health and disease: from signaling dynamics to function A Ben-Shmuel, B Sabag, G Biber, M Barda-Saad Frontiers in cell and developmental biology 9, 609532, 2021 | 54 | 2021 |
| BRCA mutational status shapes the stromal microenvironment of pancreatic cancer linking clusterin expression in cancer associated fibroblasts with HSF1 signaling L Shaashua, A Ben-Shmuel, M Pevsner-Fischer, G Friedman, ... Nature communications 13 (1), 6513, 2022 | 40 | 2022 |
| Actin regulators in cancer progression and metastases: From structure and function to cytoskeletal dynamics G Biber, A Ben-Shmuel, B Sabag, M Barda-Saad International Review of Cell and Molecular Biology 356, 131-196, 2020 | 36 | 2020 |
| Modulation of intrinsic inhibitory checkpoints using nano‐carriers to unleash NK cell activity G Biber, B Sabag, A Raiff, A Ben‐Shmuel, A Puthenveetil, JIC Benichou, ... EMBO Molecular Medicine 14 (1), e14073, 2022 | 33 | 2022 |
| Modulation of the intracellular inhibitory checkpoint SHP-1 enhances the antitumor activity of engineered NK cells A Ben-Shmuel, G Biber, B Sabag, M Barda-Saad Cellular & Molecular Immunology 18 (5), 1314-1316, 2021 | 14 | 2021 |
| Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies G Biber, A Ben-Shmuel, E Noy, N Joseph, A Puthenveetil, N Reiss, ... Nature Communications 12 (1), 5581, 2021 | 13 | 2021 |
| Lymphocyte mechanotransduction: The regulatory role of cytoskeletal dynamics in signaling cascades and effector functions A Ben-Shmuel, N Joseph, B Sabag, M Barda-Saad Journal of Leukocyte Biology 105 (6), 1261-1273, 2019 | 13 | 2019 |
| Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicity A Ben-Shmuel, B Sabag, A Puthenveetil, G Biber, M Levy, T Jubany, ... Elife 11, e73282, 2022 | 10 | 2022 |
| Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022; 3: 793–807 D Lavie, A Ben-Shmuel, N Erez, R Scherz-Shouval | 6 | |
| Actin retrograde flow regulated by the Wiskott–Aldrich syndrome protein drives the natural killer cell response B Sabag, M Levy, J Kivelevitz, N Dashevsky, A Ben-Shmuel, ... Cancers 14 (15), 3756, 2022 | 4 | 2022 |
| Commentary: integrins modulate T cell receptor signaling by constraining actin flow at the immunological synapse A Ben-Shmuel, N Joseph, M Barda-Saad Frontiers in Immunology 9, 2110, 2018 | 2 | 2018 |
| Cancer-associated fibroblasts serve as decoys to suppress NK cell anti-cancer cytotoxicity A Ben-Shmuel, Y Gruper, O Levi-Galibov, H Rosenberg-Fogler, ... bioRxiv, 2023.11. 23.568355, 2023 | 1 | 2023 |
| HSF1 renders NK cells too stressed to respond Y Gruper, A Ben-Shmuel, R Scherz-Shouval Nature Cell Biology, 1-2, 2024 | | 2024 |
| Keeping IPMNs in Check: A Novel Role for the Transcription Factor NKX6-2 in Preserving an Indolent Cell Identity in Pancreatic Cystic Lesions A Ben-Shmuel, R Scherz-Shouval Cancer Discovery 13 (8), 1768-1770, 2023 | | 2023 |
| Targeting intracellular check points to unleash natural killer cell cytotoxicity M Barda-Saad, A Ben-Shmuel, G Biber, A Raiff, B Sabag, O Matalon The Journal of Immunology 204 (1_Supplement), 69.8-69.8, 2020 | | 2020 |
